{"success":true,"type":"rich","version":"1.0","cache_age":86400,"width":440,"height":500,"provider_name":"RiffReporter","provider_url":"https:\/\/www.riffreporter.de","safety":"nonadult","asset_type":"article","url":"https:\/\/www.riffreporter.de\/de\/wissen\/hiv-impfstoff-lenacapavir-prep-aids-praevention-forschung","category":"Wissen","author_name":"Ulrike Gebhardt","author_url":"https:\/\/www.riffreporter.de\/de\/autorinnen-und-autoren\/ulrike-gebhardt","title":"HIV-Impfstoff und Lenacapavir: Die Zukunft der AIDS-Pr\u00e4vention","summary":"Lenacapavir sch\u00fctzt fast perfekt vor HIV. Dennoch braucht es einen Impfstoff: Warum Forschende die Impfstoffentwicklung f\u00fcr unverzichtbar halten.","publication_date":"22.05.2025","thumbnail_url":"https:\/\/riff.media\/images\/hiv-virus-vermehrung-t-zellen.jpg?w=440&h=247&fit=crop-50-50&s=be0c14a32b7a42f106b8661bdd18bc68","thumbnail_width":440,"thumbnail_height":247,"thumbnail_credit":null,"thumbnail_credit_url":null,"thumbnail_credit_note":null,"html":"